Illinois Lawmakers Introducing Adult-Use Legalization Bill This Week

Lawmakers in Illinois will unveil recreational cannabis legalization legislation this week with the full support of Gov. J.B. Pritzker (D), according to a Crain’s report.

The measure will be sponsored in the Senate by Sen. Heather Steans and in the House by Rep. Kelly Cassidy, who noted that, if the measure is successful, Illinois would become the first state to legalize and regulate adult-use cannabis sales via the legislature.

“This bill stems from an inclusive process that entailed community meetings, town halls, and legislative working groups. In spite of having a wide variety of views, most of us wanted the same basic things—social justice, safety for our kids and revenue for our state. I think we’ve done a good job of balancing these three goals.” – Steans, in a statement via Crain’s

The bill includes implementing a $20 million low-interest loan fund for social equity applicants – individuals from communities most impacted by the so-called War on Drugs. The fund would initially receive $12 million from the existing medical cannabis fund. Under the law, 25 percent of tax revenues derived from the industry would be reinvested into those communities.

Pritzker has long supported cannabis legalization in the state. Shortly after his election, he told NPR that he wanted Illinois to be the first state in the Midwest to legalize cannabis, despite Michigan voters giving the state a head start by approving legalization in 2016. In Michigan, regulators are still drafting rules.

It’s estimated that cannabis-derived tax revenues would be between $200 million and $500 million in Illinois annually.

End


Cannabis Plant

University of Washington Studying Effect of CBD for Fragile X Syndrome

The University of Washington is conducting a clinical trial on the efficacy of CBD for Fragile X syndrome, a type of autism believed to be linked to deficiencies in the endocannabinoid system, according to university newspaper Daily UW. The study is sponsored by Zynerba Pharmaceuticals, a company that produces a CBD gel.

The double-blind study will be aimed at children 3 to 17-years old who are diagnosed with Fragile X. The participants’ parents will rub the gel onto their child’s arm twice daily. Dr. Raphe Bernier, the study’s lead researcher and UW professor of psychiatry and behavioral sciences, who also serves as the executive director of Seattle Children’s Autism Center, said topicals “help make things easier for children with developmental disabilities.”

“There is no need to swallow a pill, which can be a challenge, or apply a patch that can be removed because it’s uncomfortable. It also bypasses the [gastrointestinal] system and many children with Fragile X syndrome have GI disturbances, and [there is] no need to introduce anything else into the system.” – Bernier to Daily UW

Bernier said that the researchers “wouldn’t anticipate” that CBD would have any impact on other autism spectrum disorders, “because the underlying cause doesn’t have anything to do with the endocannabinoid system.”

Micah Pepper, the trial coordinator and manager of program operations at the UW clinical site, indicated they are hoping for at least 10 participants and estimate the study will last about 14 weeks.

End


Oreo Maker Considering CBD-Infused Snacks

Dirk Van de Put, CEO of Mondelez (the parent company behind the Oreos brand), said the company is “getting ready” to develop CBD-infused snacks, but indicated that the company doesn’t have plans to add it to its “family brands” such as Oreo, Nilla Wafer, Nutter Butter, or Cadbury chocolates.

In an interview NBC News, Van de Put indicated the company was still waiting federal regulations about potentially adding the compound to food, which has, so far not been approved by the Food and Drug Administration.

“The space is not clear. It’s a bit clearer in non-food products. In food products, I’m hoping that the FDA will bring some clarity in the coming months.” – Van de Put, via NBC News

Last month, the agency announced they would be holding public hearings this month on the sale of CBD and adding it to food products. Currently, there are no guidelines allowing for such products to be sold.

The lack of regulations did not stop Carl’s Jr. from rolling out it’s Rocky Mountain High burger in Denver, Colorado for 4/20 last month, which was topped with Santa Fe Sauce infused with 5 milligrams of CBD.

Despite this new direction, CBD-infused Oreos do not appear to be in the cards for Mondelez. Van de Put said the company would likely create new product lines for any CBD infusions or add them to its non-family brands.

End


Department of Veterans Affairs Opposes Three MMJ-for-Vets Bills

The Department of Veterans Affairs is opposing three federal legislative proposals that would allow the VA to research medical cannabis and allow veterans access to medical cannabis products under state-approved programs, Military.com reports.

Larry Mole, chief consultant for population health at the VA, said while the Veterans Affairs Committee “can make strong proposals” for the agency “to move forward with recommendations of filling out forms and such,” ultimately the VA needs the opinion of the Drug Enforcement Agency and Department of Justice.

One bill, HR 1647, would allow VA providers to fill out the requisite forms allowing Veteran patients to participate in state-approved medical cannabis programs. That bill has been introduced every year since 2014 by Oregon Re. Earl Blumenauer, a Democrat, who said VA patients looking for relief from chronic pain and post-traumatic stress disorder overdose on opioids at almost twice the national average.

Another bill, HR 712 sponsored by California Rep. Lou Correa (D), would direct the VA to conduct clinical trials on cannabis and its effects on PTSD and chronic pain.

“It’s time to do research. It’s time for veterans to know what cannabis is good for and what cannabis is not good for.” – Correa to Military.com

The third bill, HR 2192, would prohibit the VA from denying healthcare and compensation for veterans enrolled in medical cannabis programs. Keita Franklin, the VA national director of suicide prevention, noted that the agency is participating in a trial for cannabis and PTSD but that VA physicians would be subject to criminal prosecution if they made referrals to veterans for medical cannabis access under DEA rules.

End


New Hampshire Senate Approves MMJ Home-Grow Bill

The New Hampshire Senate has passed a bill to allow the state’s medical cannabis patients to grow their own cannabis on a 14-10 vote, according to a New Hampshire Public Radio report. The House passed a different version of the measure earlier this session and the two chambers will need to reach an agreement on the final language of the legislation before it moves to Gov. Chris Sununu for his signature.

The bill would allow the state’s registered patients to grow three immature, six mature, and 12 seedlings after they register with the state. There are about 7,000 registered patients in the state but only four dispensaries to serve them.

Democratic Sen. Tom Sherman said the high price of medical cannabis products in the state has forced some patients to “turn back to opioids as a cheaper option to ease their pain.”

“We hear over and over again in hearings there is a problem with our state having so few dispensaries. It is not perfect for everyone to access.” – Sherman, during the Senate debate, via the Eagle-Tribune

Republican Sen. John Reagan, who sponsored the state’s original medical cannabis measure, said patients spend about $400 a month buying products from the state’s dispensaries and estimated growing their own would cost about $100 a month while allowing them to “concentrate the cannabis to a greater degree.”

The bill is opposed by the state Association of Chiefs of Police and Republican State Sen. Sharon Carson said the bill doesn’t provide enough protections for law enforcement to prevent theft or misuse of home-grown plants. The Senate version of the bill does not include the House provision that allowed patients to “gift” home-grown products to others participating in the medical cannabis program.

The original version of the medical cannabis bill did include home-grow provisions, but they were removed after former Gov. Maggie Hassan threatened to veto the bill if they were included.

Sununu has not indicated whether he would sign the bill if it makes it to his desk.

End


Ezra Soiferman

Ezra Soiferman: Appreciating Cannabis and Hemp With Art

Ezra Soiferman is a renowned Montreal-based photographer, documentarian, and worked as the world’s first cannabis artist-in-residence for Tweed. He recently joined our host TG Branfalt for a conversation about how he became familiar with the medicinal qualities of cannabis before the term “medical marijuana” was widely known, what it means to be an “artist-in-residence” for a cannabis brand, and how cannabis legalization has affected culture in Canada.


Listen to the podcast:


Read the transcript:

This episode of the Ganjapreneur Podcast is made possible by 420-friendly service providers in the Ganjapreneur business directory. If you need professional help with your business, from accounting, to legal services, to consulting, marketing, payment processing, or insurance, visit the Ganjapreneur business directory to find service providers who specialize in helping cannabis entrepreneurs like you.


TG Branfalt: Hey there. I’m your host, TG Branfalt, and you are listening to the Ganjapreneur.com Podcast, where we try to bring you actionable information and normalize cannabis through the stories of Ganjapreneuers, activists and industry stakeholders. Today I’m delighted to be joined by Ezra Soiferman. He’s a Canadian artist, photographer, documentarian and cannabis advocate. He’s a former artist in residence for Canadian cannabis company, Tweed, whose work currently appears in their visitor center. His first film, Pressure Drop, released in 1993, told a fictional story of a grandfather who used cannabis for glaucoma, and follows the Pressure Drop Club through their personal journey to treat themselves with medical cannabis. He’s also directed Grass Fed, a documentary focusing on Canadian actor and comedian, Mike Patterson, in his quest to use a cannabis and hemp rich diet to overcome sciatica.

Additionally, Ezra started the Hemp for the Homeless Project, which collects functional and nutritious hemp products from help companies to create Hemp Help Kits for folks in need. Welcome to the show, Ezra. This is the first time you’ve been on. This isn’t the first time we’ve chatted. How are you doing?

Ezra Soiferman: I’m doing fantastic. Thank you so much, TG.

TG Branfalt: I’m super delighted to have you, as I said at the beginning. Before we sort of get into that laundry list of stuff that you do and have done, why don’t you tell us about your background and how you’ve come to focus on cannabis and hemp?

Ezra Soiferman: Well, back in 1993, I was living in New York City and going to NYU Film School. And a buddy of mine, Marc Ostrick and I, we discovered this newspaper article that was all about a woman who was growing cannabis for her son for his medical conditions. This was in ’93 before medical cannabis was a thing. It was certainly being used, but in a limited way across the states and across the world, compared to today. And we kind of capitalized on this, and turned it into a short film, which I’ll tell you more about. But it also opened my eyes to hemp and the versatility and the history and the awesomeness of that sister plant to marijuana.

And there had been some exposure to cannabis back in the day at the end of high school and reading about it, and seeing High Times Magazines at magazine stores in Montreal, where I’m based. It kind of crept up on me. And then once me and Marc got set on the Pressure Drop journey, that’s when everything opened up, and we started researching it and kind of living the experience and seeing how this has changed our world.

TG Branfalt: How’d you find the story for that 1993 film, when medical cannabis, as you said, was not really widely used, and was far less mainstream in the United States?

Ezra Soiferman: Well, there was a newspaper article in the New York Times. And we basically combined that with my grandfather’s story. My late grandfather, Benny Pofelis, he had glaucoma, and never used medical cannabis for his eyes. It wasn’t offered to him and it wasn’t really much talked about or known up in Canada at the time. I certainly didn’t know about it. But then when we saw this article and these other articles about glaucoma, cannabis, we took my grandfather’s story, mixed it in with our imaginations, and created something that was a bit of a fantasy on medical cannabis back then.

And you have to understand. If we think back to ’93 and the ’80s and before that, almost all of the medical, sorry, almost all of the marijuana movies that were being made were either Cheech and Chong films, mentions in comedy movies, Reefer Madness movies. There was not a lot, if anything, going on in the medical marijuana film making scene. And we said, “You know, we’re going to do this.” It’s our thesis movie. And we ended up producing this 18 minute film that came out of left field, took our university by surprise. Then it got a Warner Brothers Pictures award from the school. And it went on to play 25 film festivals around the world. It opened up our careers. I think it’s because we took this, at the time, obscure stigmatized topic and turned it into a comedy that could be accessible from different angles.

We found actors who were seniors, who weren’t using medical cannabis, but we told them about the script. They were willing to take a leap and act in a film like this. And they were actors who were from the old Yiddish theater scene back in New York City. Yeah. We found them through the Second Avenue Deli by asking the maitre d at the restaurant if he knew of any good classic senior Jewish actors. And he said, “Walk down the street to the Hebrew Actors Union.” So we ventured down Second Avenue, and hung a right onto, I think, East Sixth Street, and went upstairs. And there was a whole dinner going on with all these veteran, 70 something and 80 something Jewish actors. And amazingly, that place still existed at the time. And the first woman to approach us at the door asking us why the heck we were there, these two pip squeak young filmmakers. We said, “Do you act?” And she said, “I was in Avalon. You know Betty Levinson? I was in Avalon.”

And sure enough, she was in Avalon for about three seconds onscreen. She did a fantastic job for those three seconds. And she used to be on the Yiddish stage back in the day. And then she found the costar, and we turned this into a really cool, fun movie. And people could still watch it now if they just Google Pressure Drop movie. It’s at pressuredrop.com.

TG Branfalt: You said that it sort of took your school by surprise. What was the reaction at that time?

Ezra Soiferman: Well, first of all, we were supposed to make a three to five minute movie, and we ended up making an 18 minute movie. And showing the script to our teacher, he said, “Look. You guys really seem to have it together. You’ve done your research. You’re two people making a project together. Co-directing can be tough, but you and Marc, if you’re comfortable, I can bend the rules and make it. See what comes of it.” So we weighed the options and we said, “Let’s go for it. This is a once in a lifetime opportunity. And we have a story that we feel is special and needs to be told now.” And we did so.

And then we worked for months editing it with classmates, and put something together that we were ready to show. And right away, like I said, it got the Warner Brothers award. And then it moved on. We hustled. We sent it to the New Orleans Film Festival and out to London and to California, up to Canada. And many of the film festivals accepted it, and then spread the word to other film festivals. It just opened up our careers. Who at the time was making medical marijuana movies? Basically nobody. And we said, “Look. Let’s take this and see where it goes.”

And it wasn’t something where I felt like, okay. Now I’m going to make marijuana movies for the rest of my career. This is it. I still have a huge curiosity for so many things on our planet, as beautiful and troubled as it is. There’s so much to see. And I’m grateful and thrilled to know that I’ve discovered cannabis 25 years ago. And it stuck with me all this time, the passion and the fascination with it hasn’t abated at all. 25 years, you have to understand, that I’m still reading about this every single day. But I found other things too. I love making movies about food, different historical things. I have a medical interest. Cool, random people, underdogs. I’m just grateful that we took Pressure Drop, we ran with it, and it opened things up.

TG Branfalt: More recently, you’ve worked on Grass Fed. How’d you come across Mike Patterson?

Ezra Soiferman: Mike Patterson comes from a long line of Canadian kind of goofball, oddball, big, lovable, friendly, accessible comedians. John Candy comes to mind. And Mike, I had seen him performing here and there over the years. He lived in my neighborhood with his brother for a little while. And then a friend was directing a short film that starred Mike. And I worked on that as a camera guy back, must’ve been about 15 years ago. So we met and talked and hung out during that shoot. And then this was about 2013 or so. Edibles were starting to catch on in California. Colorado would soon have legalized recreational right around that time.

I basically knew that edibles was going to be something that would ramp up rapidly and become a huge option for patients and for consumers. And I wanted to make a TV series about edibles, exploring that world. So I went to a production company in Montreal. It’s a big Canadian production company, and they do really successful and creative stuff. And told them the idea. They loved the idea of doing this kind of survey of the edibles world. But we were trying to focus it down. And we said, “Maybe if we find a host, the host can help us focus it.” I actually put forward Mike’s name as a potential host. They liked the idea. But we had a number of different names. And then coincidentally, a couple of days later, I bumped into Mike Patterson at a theater, the Segal Center in Montreal, where I used to work, after a play I was seeing there. He was in the lobby. He had just finished performing in … I’m forgetting the name. Always be closing. What the heck’s that thing? Anyhow, some awesome play that I’m spacing on.

Some of your listeners will know Always Be Closing. It’s Glengarry Glen Ross. He was starring in that. And Mike and I talked in the lobby. And I said, “Mike, I’ve got this edibles project. And maybe it’s something that would be up your alley.” I was very kind of low key about it. And he said, “Listen, I’ve got a secret. I’m now taking edibles for my sciatica. Nobody knows this except my fiancee because she makes me the edibles. And basically, she’s the only one who knows this, and it’s started to work. I’m able to manage my pain from my sciatica. But I can’t tell my agent because she’s going to not want to send me out on jobs. And acting gigs are going to be skeptical of a guy who has a known medical condition. So I’ve kept it low key. But I have horrible back pain, and every night I’m lying on the floor, Ezra. And I can’t deal with life, but the cannabis has started to help.”

So I said, “Okay. This is perfect. Let me get back to you and see if we can work together.” So I went back to Muse, the production company. They said, “This is amazing. Let’s do it all about Mike and his journey. Forget about a TV series. Let’s make a feature film,” so we did that. We made a feature movie that went on to explore Mike’s journey as he changed his lifestyle, changed his eating habits, changed his medical regime, and became a legitimate legal medical cannabis patient in the Canadian system that had started back in 2000. Now it was 2014, and I was following Mike as he joined the system. And the film is wild because I follow Mike to California, to Colorado, as he learns about what edibles are and how they can help patients.

And then I don’t want to give anything away, and there’s a lot to give away, but I don’t want to. But basically, he turned his life around. And the change that we see happen in his health and his weight and his love life goes from zero to 60 very quickly in that movie. And Grass Fed is something I’m really proud of, and it ended up on television across Canada on the CBC Documentary Channel and Australia. And now it’s on iTunes and Google Play. And it’s had a beautiful run, and I loved working with Mike. He’s a riot, the guy.

TG Branfalt: In the United States, we recently, the Superbowl just happened. And they actually blocked a medical cannabis commercial. Meanwhile, they’re inundating us with booze ads. We get a little bit of the culture with Vice, and CNN with Gupta has done some stuff on medical cannabis. However, it’s very unlikely that you’re going to see sort of feature films well-placed on any mainstream American channel. How’d Grass Fed end up on the CBC Documentary Channel? What was that process like?

Ezra Soiferman: Well, like I said, my producer was very talented in what they do. A producer of a movie basically takes the idea and they find the director. They find the actors. They find the money and they find the broadcasters. In my case, because it’s a documentary, we didn’t really have to find too many actors, or any at all other than the comedian. They found the director in me because I approached them. The last thing was finding someone who would show this movie and help to get it funded and produced. And they basically had a meeting with an executive at the Documentary Channel. And he loved the idea. And he basically recognized that edibles were coming. Edibles were not yet legal in Canada for patients to purchase. They’re still not legal for … You can’t buy cannabis brownies or anything like that as a medical patient through the licensed producers in Canada, still.

However, you can as a patient now make your own edibles at home, or in some cases, have someone make it for you. But we’re still not quite there yet. However, this coming October, Canada will have edibles and extracts and other things legal in shops across the country for recreational. And medical will follow. And patients can go and buy edibles then. So a lot has changed since I made the movie, but still many things sadly have not. But you know cannabis. It’s an ever evolving thing. And we never know what tomorrow brings or what October brings. So I’m really excited that Grass Fed was a little bit ahead of the curve. And now edibles have continued to grow in popularity. And it’s helping people.

TG Branfalt: I mean, you sort of have stayed ahead of this cannabis curve throughout your career. When we met in Burlington, Vermont last year, you were still an artist in residence with Tweed, which isn’t something that a lot of people, if anyone else, can say. Could you explain what that actually means and what you did in that role? And how did you land such a cushy gig? Pardon the pun.

Ezra Soiferman: Ha. Basically, one evening in Montreal, I had this brain wave. And I said to myself, “You know, there’s all these places that have artists in residence.” And I see them as an artist, as a filmmaker, and a photographer. I read these postings in newspapers, or blogs, magazines, about people who are selected as the artist in residence at a museum, at a gallery, sometimes at a company. And I was always fascinated by the process of a corporation taking an artist under its wing and supporting him or her to create their art, often doing so in a completely independent, hands off way. What a dream for an artist to have that kind of support. And it reminds me of back in the day when the painters, the famous painters, were in some cases supported by wealthy families, or people with means to do such a thing. They would support their art.

And I simply believe more artists should have this access, so I had this idea. I’ve never seen an artist in residence featured at a marijuana company. The closest thing was back about 10 years ago, a hemp company in Canada had a hemp fueled filmmaker. That was the only thing that I’d ever seen similar. And by coincidence, that hemp fueled filmmaker was me. So other than me, I hadn’t seen anyone as an artist be supported by a cannabis company. So I said, “Okay. I’m going to make a proposal and pitch this,” to what at the time, and still to this day was my favorite cannabis company, legal cannabis company, which was Tweed, which is owned by or part of the umbrella of Canopy Growth, which is a massive cannabis company that has reach around the world. They’re in about 16 countries now.

And I loved the Tweed brand from day one. When I read the first press release about Tweed in early 2014, I knew that they had a story. And I love stories as a filmmaker. And I could tell right away that these guys were thinking about more than just growing marijuana legally. They wanted to create a concept, lifestyle, and I guess a bit of a cultural fingerprint on the cannabis scene up in Canada. And they first leased the old Hershey’s chocolate factory. Then they ended up buying it. And now they’ve expanded it, so it’s a massive campus that they have in a small town in Ontario called Smiths Falls. And when I read that first press release back in 2014, I said, “I want to somehow be in the constellation of this company, in their world.”

And I wrote a letter to the CEO back then. I sent him an old Hershey’s calendar that I found at a garage sale. And just like I liked to do even when I was a teenager, I just kind of approached these companies that I respect, and I try to tell them that I dig what they’re doing. So I did, basically for several months there was no further contact with the company other than me following what they were doing and how they were growing so quickly. And then one night, I had this idea to pitch them that they should be the world’s first company to have an artist in residence, and I should be the first artist in residence. So I didn’t do it. I didn’t send it off. I told my best friend, one of my best friends, Paul Flicker. I said, “Paul,” and Paul’s one of the guys in this world that has the best gut feelings about everything. He’s been right about virtually everything I’ve ever asked the guy in my life, except one thing. I said, “You think Trump’s going to win the election?” He just said, “Not a chance. Not a chance.” Other than that, Paul has had impeccable foresight.

And I said, “Paul, what do you think of this idea?” And he said, “It’s genius. There’s nobody else who could do this. Tweed is perfect. You’re perfect for it with your cannabis background and your film making career, your photographs. Go for it.” So I wrote up this one page pitch, and I got it ready to send to the guy who was then the president of the company, who I had filmed with Mike Patterson a few months earlier when I called Tweed and said, “Can I film this guy who wants to see where his cannabis is being grown?” I followed Mike Patterson out there and we filmed with a guy named Mark Zekulin, who was then the head of legal affairs at Tweed. Then he went on to become the president.

And I waited with that proposal for artist in residence. I waited until he saw Grass Fed, which was about to air on television. I wanted to make sure that the guy liked it, and that I didn’t offend them or portray them in some light that they thought wasn’t right. Anyhow, long story short, two days later after the movie aired across Canada, Mark writes me this email. Wow. We loved your movie. Thank you so much for showing this patient at our place, and if there’s ever any way we could help you out in the future, our door is open. Boom. I run down to the local courier office, and I sent off his package with that proposal and with copies of my movies and with photographs. And I pitched them this concept of being the world’s first cannabis company to have an artist in residence, and how it would help them get the word of their company out there, how it would support an artist, how it would help the arts and help cannabis and help me get the word out about hemp and medical cannabis, et cetera.

Anyhow, they loved the idea. A few months later, we had a deal signed. And they basically financed new equipment and travel. I went to about 12 different cities over that period of one year. They gave me an honorarium. And they made me feel like part of the team and have me essentially, literally carte blanche to do whatever photography I wanted. It wasn’t even just cannabis photography. Not only did I have access to film in their facilities, but I also had access to their staff and to photograph the people who work there, and photograph the … I even went down to Jamaica with some of their staff and photographed them doing kind of scouting down there. They’ve since opened up a facility in Jamaica. And I traveled to all these different cities doing stuff about cannabis, about cars, about guitars, about you name it. I was out there making my art and supported by essentially the world’s largest cannabis company. A dream come true.

TG Branfalt: You take incredible photos. I’m lucky enough to have one hanging in my office. And it’s unfortunate that this isn’t a video podcast, so we could display some of these things while you’re talking. But people can find them. We’ll get to that a little bit later on where they can find your stuff. But what does it mean to you as an artist to now have your work featured in the visitors’ center of the world’s largest cannabis firm?

Ezra Soiferman: A complete honor. They called me one day last August or so and said, “Listen, we want to feature your art upstairs in the new visitors’ center in Smiths Falls, Ontario,” which is about 45 minutes out of Ottawa, a couple hours out of Toronto, a couple hours out of Montreal, kind of in the middle of nowhere in Ontario, a town of 10,000 people. They built this visitors’ center in the old Hershey’s chocolate factory’s visitor center, where Canadians … You have to understand. This visitors’ center was the biggest visitors’ center in all of Canada. People would go there and buy bags of broken chocolate. You can ask nearly any Canadian, especially nearly anyone from Ontario, and they will know that place. And they will have gone there when they were a kid. And now they say, “Oh my God. That’s now a cannabis visitors’ center.” And sure enough, it is. It’s basically part museum, part coffee shop, part chocolate factory, part grow operation. There’s a terpene center where you can go and smell all these different terpenes.

TG Branfalt: No way.

Ezra Soiferman: There’s staff taking you on tours. And my work is now upstairs on the catwalk area. When you walk around and look down at the chocolate edibles facility, and then you look on the other side, you see the grow rooms, my art leads you through it and helps to show additional things from the factory that the guests can’t see through the windows. There’s pictures of the vaults and of the mother room and of the staff and of the R and D labs. And 25 large print frames of mine are up there.

And it’s been like I’m still kind of dreaming because I drive down to this place once a month, twice a month, for meetings and to meet people and stuff, to see the new things going on there at the factory. But I also then go visit the visitors’ center. And I walk in, and it’s like a little cannabis museum with my stuff as the first artist featured there, so I’m totally blown away by it. And the feedback has been amazing. People can see a lot of those pictures can be seen in the video that I made summing up my year as artist in residence. It’s kind of like a greatest hits video called Ez in Res. And that’s on YouTube, and it’s on my site, et cetera. It’s been wild.

TG Branfalt: Is there sort of this double layer of excitement for you, being that it’s hanging in this place that you visited when you were younger?

Ezra Soiferman: Well, I didn’t actually go there when I was younger.

TG Branfalt: You’re the only Canadian that didn’t go there when you were a child.

Ezra Soiferman: I think there were three Quebecers who didn’t go, and I’m one of those. And I think that’s it. But I had heard as a kid, I always heard, “Yeah. We got this bag of chocolate for $5. We got about $50 worth of chocolate.” It’s all broken and half melted, but it’s delicious.

TG Branfalt: In 2007, you launched your Hemp for the Homeless program. Tell me about the conception of that program and how you’ve kept it going for more than a decade.

Ezra Soiferman: Okay. This filmmaker in Montreal, who was an acquaintance of mine, had a movie about a penny. And he was going to bring this penny to life. And he wanted to get a name for the penny who was going to star in the movie. It was this whole crazy thing. He said, “I’m doing a contest. And anyone who could give me the name that sticks for the penny in the movie will win 500 bucks.” I had never heard of anything like a contest like this. First of all, for an independent filmmaker to be giving away $500, that alone is like, whoa. What’s up here? Someone doesn’t have a good business model. Anyhow, he did it. And he made this contest. And sure enough, I applied with a couple of different names. And I love words. That’s one of my passions, words, and languages and coming up with names. And people know me for that. I’ve given people titles for their movies. And I pick interesting titles for my movies.

TG Branfalt: Anyone who follows you on social media can definitely attest to that.

Ezra Soiferman: Yeah. Thank you. I try to add to my images with words and tricks of phrases that are hopefully almost as clever, or as interesting to read or look at as my pictures. What do you call it? It’s a multi pronged approach I take. Anyhow, I went for it with a name. My name was chosen. The name that I submitted was Juan, like J-U-A-N, Redcent. Juan Redcent. And he picked it. I got 500 bucks. And I said to myself, “I don’t want to buy myself $500 worth of stuff that this poor filmmaker gave me.” I accept it, but I want to put it to good use. So at the time, this was 2007. I had already been into hemp. And hemp was pretty much always my main focus, more than medical cannabis, more than recreational. I’m all in on hemp, and was from day one. The versatility of this thing, the environmental aspects of hemp, the historical aspects, the cultural aspects, it covers all the bases. And it’s still so little known and little used that I see massive potential here.

I took the $500 and I said, “I’m going to use that to help homeless people in Montreal.” And I called up all these hemp companies that I know in the states and Canada, and got all this hemp stuff sent to me, soaps from Dr. Bonner’s, and T-shirts from Hemp Town in British Columbia, and hemp lip balm from Eco Lips down in the states, on and on and on. And I made these hemp tote bags filled with hemp stuff that was functional and useful. And ultimately, I like to think that 50 people, who didn’t have all these T-shirts and socks and functional things, that it helped them out in some way. Look, 50 people benefited. It’s not at all making much of a dent in the crisis in Montreal and Colorado and across the states and Canada that we have with homelessness. But it’s my little part to help out and to help show that hemp can pitch in. Where anything else can, hemp can join in, if not take over.

I did that in 2007. Then I did it again at the NOCO Hemp Expo in Colorado in 2017, and then again in 2018. And now I’m heading back this year. We’re going to do some more help kits for people in Colorado, and on and on it goes. I want to grow it. I want it to be something that more hemp companies can get involved with. I want other people in other industries to see this and make them think about how they could help homelessness. And little by little, we chip away, and hopefully big strides.

TG Branfalt: Well, I want to switch gears a little bit and talk to you about policy. Last year, Canada legalized cannabis for adults use. Can you tell me how it has or hasn’t changed the life of the average Canadian citizen?

Ezra Soiferman: Wow. If you would’ve asked me before October 2018 when it was legalized how it would change things, I would’ve thought then that it would’ve been more of an outward change, that we would’ve seen more people smoking on the streets, or talking about it, or having cannabis themed parties. But to be totally honest, as great as it is that cannabis is now legal for recreational purposes and adult use purposes in Canada, when you walk around the streets, you don’t see any difference other than the four cannabis stores that are in the city of Montreal. So there’s really not much outwardly. It’s not like walking down Broadway in Colorado, or down Los Angeles, West Hollywood. You just don’t see all those dispensaries, so it’s pretty low key on the streets.

Montreal has always been a place where you’ll see people smoking on streets, like they’re smoking a joint, or a vape. And you’ll smell it. But I honestly have not seen a huge difference in that. People have talked about it. The press has covered it. It’s definitely something that made a big splash, but the sky has not fallen. We’re not seeing people crashing their cars into fire hydrants. I’m not hearing people complaining. There have not been line ups at the hospitals. I think it’s kind of business as usual, but now they’re selling cannabis online and in stores. And I think it’s a fantastic thing.

TG Branfalt: You’d mentioned earlier that edibles still aren’t available. What do you think about the law as it stands right now? What needs to be addressed to make it better in your estimation?

Ezra Soiferman: Wow. Well, it’s a big set of laws. It’s a big bill that was put forward. And there’s all sorts of new rules and revamp of old rules. It’s pretty mammoth of how complex it is, for driving and for the ages of who can consume. I think it’s imperfect. I think some of it is problematic. In the province of Quebec, where I live, you cannot grow four plants at home, as you can in virtually every other province and territory of Canada. You can’t grow any plants at home. The province of Quebec wants to make 21 and over instead of 18 and over. Some people are calling it … Canadians across Canada have called it prohibition 2.0.

TG Branfalt: Interesting.

Ezra Soiferman: Yeah, because there are so many new rules around this stuff. You can’t smoke it here, and you can’t take it there. To some extent, you could call it that. And another way of looking at it is, look, it is actually legal. There are many legal things that one can do with the plant now. And that’s a big, big step. And we’ve opened the door now to making other additions to the rules, or modifications. Things, I imagine, will evolve. And as an old boss of mine said when things were chaotic, it’s a work in progress. And we’re going to get it right. Hopefully, that the direction Canada’s taking. I think it’s a huge step that we’ve taken. It is not perfect. That’s my own personal opinion. But we’re getting there.

TG Branfalt: What’s been your experience as a consumer living in a now legal market?

Ezra Soiferman: Well, I’ve gone down to see the stores in Montreal. There are four stores across the city, spread pretty widely, so that it gives access to people across the town. And it’s interesting. When you go into a dispensary in Colorado, you’re like a kid in a cannabis factory, or a kid in a candy factory, with all the selection. And it has not gone as smooth in Canada with the roll out, so you do see empty shelves. And you see line ups at the door sometimes. The first month, there were line ups pretty much every morning before the stores opened. So much so, they couldn’t keep the shelves stocked. And they ended up closing the Quebec stores, and they’re still closed every Monday, Tuesday and Wednesday. It’s a little ridiculous that we have these very handsome shops. There’s all sorts of wood shelving, and there’s tons of staff, lots of customer service. They’re wearing these beautiful aprons with the logo of the Quebec SQDC, which is the name of our cannabis liquor, not liquor, the cannabis commission.

They’ve got these aprons on. And they’ve got some nice products from some of the big and medium sized producers, even smaller ones. Customers seem to be happy. Every time I walk by or walk into one of those places, there’s still crowds in there. It’s nice to see a business thriving. Don’t get me wrong. But it’s been a little rock and roll the past few months since it opened. It hasn’t been perfect. But I know that people are going back. Friends, or strangers even, that I’ve discussed the topic with have said, that they’ve gone into check with these stores, and they were pretty impressed. So we’re getting there.

TG Branfalt: On your end, and I only know what I know of you, was there any … When those laws passed, were you able to sort of take a deep breath and be like, “I’m not a criminal anymore”?

Ezra Soiferman: Yeah, a really deep breath. Absolutely. I literally cried several times along the journey towards legalization because this is something that’s so close to my heart, and something I’ve been so fascinated with on a global scale, not just Canada, but whenever there’s a big stride in legalization, or in science even, medicine with cannabis, or some brilliant new product that comes out that’s hemp or technology. It warms my heart because it’s like a child of mine, this plant. I like to see it growing up. And I missed the first 10,000 years of its history. But now that I jumped in as a person on this planet to witness this, it always makes me happy to see. What can I say? Legalization is a big step that Canada took. It was pretty ballsy and-

TG Branfalt: They were catching flack from the UN.

Ezra Soiferman: Catching flack from everybody pretty much, except for that percentage of the population who voted the liberals and Justin Trudeau in to do this. And I was following the elections closely. And when he won, and he said, “We’re going to legalize cannabis in Canada,” that was one time that I shed a tear. And then when the laws started passing and going through the Senate, that whole journey was very fraught with ups and downs. It was a roller coaster. And we really didn’t know if it was actually going to happen. There were all sorts of times where it was questionable as whether this would pass. Sure enough, it did pass. And it has arrived. And the sky hasn’t fallen. And people have generally, from those I’ve talked to, seem to be thumbs up. We’ve done this and now life goes on. But now we have the ability to consume without being a criminal.

TG Branfalt: In our conversations, you’ve said that you’re obsessed with hemp. Last year, via the farm bill in the US, hemp was finally legalized, although there’s been some restrictions. There’s still been some police, overzealous police officers are finding truckloads of hemp in the US, and they arrest the driver. And then they have to do this expensive testing, and so on and so forth. Was that US legalization of hemp, for you, where does that fall in sort of the importance scale for the significant scale for you?

Ezra Soiferman: Big, big thing. And the fact that it was Trump who signed it in, was, I don’t know if ironic is the right word, but certainly strange. There’s a lot of people who have things to say about him. And one thing that they will be able to say down the road is that hemp became legal under Trump. So for what it’s worth, that was super interesting to watch happen. And I was really excited about this farm bill as that was making its way through the system in the states. I knew it would be a big thing. Sure enough, it is a big thing. And it opens the doors to absolutely everything and anything on the hemp front because as we Canadians know, when you Americans go for it, you go for it. So hemp could turn into what I predicted years ago.

I’ve said for many years that I think hemp is going to be the next digital. Remember back in the ’80s, digital this and digital that. And then I said, “When we hit peak digital, it’ll be when there’s the digital toaster.” And sure enough, now my toaster has digital circuits in it. They sell toasters that’s digital. I think digital, the whole fascination with, oh, it’s digital, it’s digital. I think, I think, I suspect, that hemp will be the next digital, where people are going to say, “Yeah. I got a hemp T-shirt. I got my hemp in my car panels in my car. And I got a hemp hat. And I got this. And I eat hemp for breakfast,” because it could touch all the things that digital can touch, which is basically anything.

There’s nothing on the planet, as far as I’ve found, that’s as versatile as hemp, other than maybe water, or air. But you can’t build a table out of air. And you can’t make a T-shirt out of water itself. You can’t eat water as nutrition, but yet you can make a table out of hemp. You can drink hemp. You can make a T-shirt out of it. It’s so versatile that the fact that we’re overlooking it … Hemp is only in about 4% or 5% of fridges or pantries in Canada and the states. There’s only 5% of people who have it at home. As that starts to ramp up and people start to discover it and to have it in more of their mainstream foods and more of their fridges and pantries, which I think will be happening, can you imagine the billions flowing into this, and the interest and the product development? And the usefulness of this plant will finally be appreciated, exploited, and understood.

And I think it will be for the better. I honestly think that the hemp ramp up will be for the better for everybody. It’s kind of inevitable that a plant with such versatility shouldn’t help make society a better place. It does so many other things. Why shouldn’t it do that? And then you look beyond that, it could help with climate change. It could help with social issues and with jobs. The list goes on and on and on. It’s not just about the fact that you can make running shoes out of it, or bags. But it could be good for society in general. The farm bill, to answer your question, was massive.

There are still things to iron out about it with CBD. And is it a food? Is it a medicine? But they’re going to figure it out. And the money is there to be made. And the people are out there to buy it. And as long as we educate the average person as to what hemp actually is, then we have a chance of growing more of it and selling more of it, because if we don’t tell people what hemp is, they’re still going to be in the dark about it. They’re still going to have a stigma around it. And it won’t quite work. But if we got the education, and we’ve got the product development, we’ve got good luck, we’ve got good investment, limitless. Potentially, even bigger than digital.

TG Branfalt: You’re a heck of an advocate for hemp. When I met you in Burlington, from head to toe, you were in hemp clothing. I’ve got to ask you. What’s your prized hemp possession?

Ezra Soiferman: Wow. I have all sorts of hemp stuff in my place because I’m a collector of this too. I have boxes filled with samples of different hemp things that I will bring to a lecture, or go through and organize. Sometimes I’ll show stuff online from the collection. My wardrobe is all hemp. I’ve got jackets and hats, shoes and bags, hand creams and lotions. To pick my favorite one thing, one thing that comes to mind that’s top of mind, pardon the pun, is a yarmulke, a kippah, a Jewish ceremonial head covering that I wore at my wedding that I had custom made, custom made by this dude, who was a third generation hat maker. And I photographed the process.

And I got him the fabric from Enviro Textiles in Colorado, from those guys who are geniuses of hemp fabric, Summer and Barbara Filippone. I got him the fabric. It’s this chocolate brown herringbone material. And he made this beautiful design for a kippah. And I wore it at my wedding, and gave these hemp kippahs out to all the people who were at the wedding too. And to this day, the kippah’s right on the shelf near me. I’m feeling it now as I’m talking. It’s in perfect condition, and I’ve worn it to many funerals and bar mitzvahs and weddings. It actually fared a lot better than my marriage did. Hey, that’s life, and I’m still on very good terms with my ex wife. And I’m on very good terms with hemp to this day, so there’s no problem.

TG Branfalt: That’s hilarious, Ez. What advice would you have for young artists who are considering sort of taking the path that you did, and sort of centering their art, or trying to sort of breakthrough with their art, focused on this industry or this culture?

Ezra Soiferman: Go for it. There is really so much to be done to bring arts to cannabis, and to bring cannabis to the arts. Art is tens of thousands of years old, as well as hemp. They both existed side by side, being something that for humankind was important and nourishing and appreciated. And when I dreamed up the artist in residence gig for myself with Tweed and Canopy Growth, I knew that I was onto something. I knew that I wasn’t see the arts represented in the cannabis industry very much, or at all almost. And I knew that I was the guy to give it a little kick and see where I could take it. And I’m really, really pleased with how it’s gone. And I’ve told artists along the way to go for it too, to reach out to cannabis companies, to hemp companies, and to offer to collaborate, to make partnerships, to do special events, to put art on their walls. There’s so much that could be done to put more color into the cannabis world.

Right now, the focus with cannabis, it’s money. It’s products. It’s growth. But we have to remember one thing that ultimately, this plant brings so much fun to people, so much enjoyment, pleasure. It takes away pain. It inspires. And people can’t lose sight of the fun aspect of cannabis, the colorful aspect. And I think the arts is a perfect vehicle to bring that over and have it be appreciated by those companies and by their customers and their clients, and make this cannabis space, this cannabis world, and the legal world on the streets, a more artful place. It’s up to the artists to do that, and it’s up to the cannabis companies to be open and inviting to these people who have the goods to share.

TG Branfalt: Well, this has been a lot of fun, man. You say that the cannabis industry is fun. This is one of the more fun interviews I’ve had. I’m lucky to know you and to be able to have this opportunity, and to have met you. We’re just across the border from each other now, so I’m sure that we’ll see each other in person soon. But I really appreciate you coming on the show. Where can people find out more about you, follow you, your social media, all that stuff?

Ezra Soiferman: All right. Well, thank you so much, TG, first before I give out any web addresses and stuff. It’s really been a pleasure to talk to you. It’s always, for me, it’s always an honor to share my cannabis experience and to talk about hemp and all this stuff. At a party, people will ask me a question, and then 30 minutes later, we’re still talking. And it’s me who’s saying, “Listen, I don’t want to talk your ear off.” And they’re like, “No, tell me more. Tell me more.” I never get tired of talking of this stuff. And when you and your podcast invited me on, I was really happy to hear that. And it’s great to be able to share with you and your listeners and to spread the word a little bit more because we all have to do our part to get the word out there.

As far as seeing my stuff, it’s on the web everywhere and anywhere. But the best place to learn more is to go to my own personal website, which is ezrasoiferman.com. E-Z-R-A-S-O-I-F-E-R-M-A-N, Soiferman. I would’ve been Hempferman, but that was taken. Anyhow, ezrasoiferman.com. And there, you can look into my photographs, my movies. I have a YouTube, Ezra Soiferman also. I’m big on Instagram, @EzraSoiferman. I’m on Facebook. People are welcome to join me on Facebook. I’m big into telepathy. People could contact me anytime. I answer emails. Every email gets answered. I’m open, and I love you guys. And thank you so much.

TG Branfalt: Thank you. And you’re one of my Facebook feed, when I see your stuff, your faces, the back of the heads, just some of your series are really excellent, even when they’re not hemp related. Once again, thank you so much for coming on the show. It’s been great. I can’t thank you enough.

Ezra Soiferman: My pleasure, TG. Thank you so much. And all the best to you and to your fellow Americans. I love you guys. And I want to see you in Canada, and I want to see you in the states. And I want us all to do more great things in the world of our favorite vegetable, cannabis.

TG Branfalt: Thank you. You can find more episodes of the Ganjapreneur.com Podcast in the podcast section of Ganjapreneur.com and in the Apple iTunes store. On the Ganjapreneur.com website, you will find the latest cannabis news and cannabis jobs updated daily, along with transcripts of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. This episode was engineered by Trim Media House. I’ve been your host, TG Branfalt.

End


Cannabis Nuns California

‘Cannabis Nuns’ Lose Banking Services After Documentary Trailer Release

The founder of California’s Sisters of the Valley, Sister Kate, says her bank has frozen the organization’s business accounts following the release of the trailer for the documentary about her, her sisters, and her business, “Breaking Habits.”

In an email with Ganjapreneur, Sister Kate, whose real name is Christine Meeusen, indicated she had the account for nearly four-and-a-half years and during that time “there has never been a banking issue or problem and [Sisters of the Valley and Meeusen] have always remained in good standing” until the bank sent her a notice on Jan. 8 – the same day the trailer was publicly released.

Sister Kate notes that, through the account, there were neither cash sales nor withdrawals as all business is handled via credit card sales.

“As 100 percent owner of the LLC and the brand, I have a clean credit history and a clean everything else history. No open parking tickets, all taxes paid current, no open litigation except in the battle for stolen resources from my ex-husband. There is no reason we should lose banking at this time. We have a 100 percent customer satisfaction policy and a charge-back rate on our credit card purchases that is unheard of. Less than .1 percent.” – Sister Kate in an email

Sister Kate suggests that the account closure is directly related to the “Breaking Habits” trailer release, which she said made the Sisters of the Valley “look very gangster.” The film opens with Sister Kate holding a firearm and includes shots of her driving a classic car. In the email, she maintains there are “no guns” at the farm because they are a cash-less business who farm hemp products with “no black market value.”

In a Facebook video posted on Monday, Sister Kate notes that she can access her personal account – which she has had for 11 years – but she is unable to get any money owed to her by credit cards processors. She indicated the bank would have kept the account open if she maintained a $60,000 minimum balance.

“We’ve been banking 11 years with a credit union and all of a sudden a film comes out about us and it has a gun in my hand, and they ask us politely to take our business elsewhere,” she explains in the video.

At this time, she is not naming the financial institution.

The Sisters of the Valley have started a GoFundMe page as an “interim request for help” to keep the business afloat while they find a new bank. T

End


Barclays 28 Billion Cannabis Market

Barclays: U.S. Cannabis Market Worth $28B if Legalized Today

Analysts at Barclays suggest the U.S. cannabis market could be worth $28 billion if legalized today and $41 billion by 2028 “on a pre-tax basis,” according to a note to investors outlined by CNBC. If taxed at the same level as tobacco, a $41 billion cannabis market could be worth nearly $28 billion in tax revenues “across all levels of government.”

“While no bonds backed by cannabis tax revenues have been placed thus far, if federal approval is granted, the cannabis muni bond market will likely flourish, amounting to billions if not tens of billions of dollars, in our view.” – Barclays, via CNBC

The firm looked at the tax revenues in Colorado, Washington, and Nevada which were already exceeding alcohol tax revenues and, in Colorado, tobacco tax revenues. It incorporated data from the 2017 National Survey on Drug Use and Health which found about 10 percent of the total population – or 26 million Americans over age 12 – used cannabis.

In March, Democratic Sen. Corey Booker, who is running for president, reintroduced the Marijuana Justice Act which would legalize cannabis federally. Under the measure, cannabis-derived taxes would be used to fund social programs such as job training.

The measure was originally introduced in 2017 but received no floor hearing. It is currently in the Senate Judiciary Committee.

End


Curaleaf Acquires Select Parent Cura Partners for Near $950M

Curaleaf Holdings Inc. has agreed to acquire Cura Partners, Inc. in an all-stock deal worth nearly $1 billion, the company announced on Wednesday. Portland, Oregon-based Cura Partners owns wholesale cannabis brand Select, which is sold at more than 900 retailers throughout the U.S.

Joseph Lusardi, CEO of Curaleaf, called the deal another step in Curaleaf’s “journey to create the most accessible cannabis brands in the U.S.”

“The combination of Curaleaf and Select is a perfect fit. With our industry leading capacity, expansive retail distribution network and Select’s impressive sales and marketing capabilities, we intend to meaningfully accelerate our topline growth trajectory with the addition of the Select Oil product range.” – Lusardi, in a press release

According to a report from Barron’s, the companies combined revenues reached $205 million last year – more than any other cannabis company in the world.

On a conference call, Curaleaf Executive Chairman Boris Jordan called the deal all about “synergies” as the operation expects a 50 percent reduction in Select material costs and 25 percent savings in processing costs. The deal includes Select’s manufacturing, processing, distribution, marketing, and retail arms, along with Select intellectual property.

Select CBD products are not included in the $948.8 million deal.

Curaleaf already operates in 12 states, with as many cultivation sites, 44 dispensaries, and 11 processing sites. The acquisition is scheduled to close later this year.

End


Senator Crapo speaking to committee

Senate Banking Committee GOP Chair May Block SAFE Banking Act

Idaho Sen. Mike Crapo, the Republican chairman of the Senate Banking Committee, said he would not commit his committee to considering the SAFE Banking Act, a piece of federal legislation that would give protections to banks who work with state-legal cannabis companies.

The SAFE Banking Act became the first piece of major federal cannabis reforms to advance out of a key Congressional committee in March after passing 45-15 through the House Financial Services Committee; it is expected to receive a hearing on the full House floor by June.

According to Sen. Crapo, however, cannabis’ federally illegal status may deter the committee he chairs from considering the legislation. “As long as cannabis is illegal under federal law, it seems to me to be difficult for us to resolve this,” he said.

The chairman also seemed to suggest that the issue of cannabis industry banking should be tackled by the Department of Justice, not Congress.

“I cannot make a commitment as to whether we will take up legislation yet because we want to see how we can resolve this difference between criminal law and our financial law,” he said.

Crapo’s comments were made during a conference for the Independent Community Bankers of America (ICBA), according to Politico.

Notably, Crapo’s comments before the ICBA contrast directly with the organization’s own priorities. As Marijuana Moment reports, the ICBA supports, “Advocating federal legislation establishing a safe harbor from federal sanctions for banks that serve cannabis-related businesses in states where cannabis is legal under state law.”

The bipartisan bill has been co-sponsored by more than one-third of the House and one-fifth of the Senate.

End


Harvard & MIT Receive $9M Grant for Cannabinoid Studies

Bob Broderick, a Manhattan, NY-based cannabis industry investor, has donated $9 million to MIT and Harvard for research on cannabis and its effects on the brain, according to an NPR-affiliate WBUR report. Broderick said the funds could help break the taboo against researching the plant and get “two great cultural institutions involved in the discussion of cannabis in the country.”

“People take risks when they say, ‘I’m going to start doing cannabis work.’ For a young researcher at MIT or Harvard to say, ‘I’m going to pivot my career and study the effects of cannabis,’ I don’t think that’s something that would have happened five years ago.” – Broderick to WBUR

Broderick suggests his is the largest-ever private gift for cannabis research – which is out-of-reach for many researchers who are unable to get funding to study cannabis due to its federal Schedule I status; however, he doesn’t think it will be the largest gift for very long.

Last year, the National Institutes of Health announced support for more than 330 cannabinoid-related projects totaling $140 million.

Harvard Medical School professor of neurobiology Bruce Bean told WBUR that, save for THC and CBD, the scientific community “really know nothing” on many of the hundred other cannabinoids they know about.

Just about a year ago, the University of California, San Diego received a $4.7 million grant to study the effects of medical cannabis on autism.

End


Clear plastic garbage bags that have been stuffed with commercial-grade cannabis nugs.

Oregon Senate Passes Bill to Halt Cannabis Licensing for 2 Years

An Oregon bill to place a two-year moratorium on cannabis licensing backed by Gov. Kate Brown has passed the Senate and moves next to the House, the Portland Mercury reports. The legislation comes nearly three months after the state Liquor Control Commission reported the state had more than 6.5 years of oversupply with the current market’s demand.

In a statement, Democratic State Sen. Floyd Prozanski said the bill “will protect the existing legal market,” in the state.

“We currently have a flood of cannabis production happening in our state. There is a ‘green rush’ happening in our state right now and, while we support a healthy and thriving new cannabis industry, the oversupply has caused plummeting product costs. Much of the product created by this oversupply is going into the illicit market that legalized cannabis was intended to curb.” — Prozanski, in a statement, via the Portland Mercury

The measure, deemed “emergency legislation,” passed the Senate 18-0 on Tuesday; it failed in the same chamber 17-3 last month, according to a Willamette Week report.

According to the CanbyNow Podcast, the price-per-gram has dropped from $14 in 2015 to less than $7 by the end of last year. A study released last month by Oxford Treatment Center found Oregon had the lowest price for “high quality” legal flower products with an average of $210.75 per ounce.

In testimony in support of the measure, Obie Strickler, CEO of licensed producer Grown Rogue, said the industry needs to remain “financially healthy” to remain beneficial to the state.

End


Proposed Detroit Cannabis Facility Offers Free Training to People With Cannabis Convictions

A proposed cannabis processing and dispensary facility in Detroit, Michigan will include an industry training center that will offer free classes for those with prior cannabis-related convictions, according to a Fox 2 report. The announcement comes the day after state regulators announced they would begin licensing adult-use businesses in the fall.

Maurice Morton, a partner with Green Cure Wellness Inc. & Southeast Provisioning LLC and former Wayne County assistant prosecutor — who also headed the major drug unit — said the training center for budtenders, processors, and entrepreneurs is “100 percent geared toward Detroiters.”

If approved, the facility will refurbish a derelict structure in the city into several growing centers, two processing businesses, and a dispensary.

On Tuesday, the Department of Licensing and Regulatory Affairs announced the creation of the Marijuana Regulation Agency, which will regulate both the state’s medical and recreational industries. Newly appointed MRA Executive Director Andrew Brisbo said the agency is set to issue “emergency rules” for the adult-use industry by the summer.

“Giving local municipalities, other state agencies, and potential business owners enough time to plan and prepare will allow for a successful rollout of the new adult-use marijuana law,” Brisbo said in a press release.

The Agency will hold four public meetings per-year to receive public input for the state’s cannabis rules and regulations.

End


KushyPunch Releases First Cannabis-Infused, Sugar-Free Gummy

Is this cannabis’ “Diet Coke Moment”?

Los Angeles, California — Award-winning SoCal cannabis brand KushyPunch releases the very first sugar-free cannabis gummy on the market, delivering a game-changing new edible option for consumers with strict dietary requirements.

This new lychee sugar free THC gummy is a healthier take on their iconic and top-selling 100mg strawberry sativa gummy, which was recently featured at the top of a Los Angeles Times round-up on edibles.

Containing just 2.5 calories per dose, and with a low glycemic index and insulin response, this gummy is geared towards those looking to minimize sugar intake without compromising on taste or quality.

“Coca-Cola spent more than 20 years working on Diet Coke. They wouldn’t release anything under their brand name that was less than perfect,” starts Ruben Cross, founder and CEO of KushyPunch.

“We applied that same mentality to our new sugar-free gummy. We wanted to get this exactly right before it became part of the Kushy brand.”

KushyPunch’s sugar-free gummy has been a long time in the making for Cross, who was recently named one of High Times’ top 100 cannabis industry professionals. His initial foray into cannabis in 2014 was spurred by a desire to create a consistent, healthy product for patients with specific dietary needs and limited consumption options.

“When I looked at the edible market back in 2014, I saw a lot of high calorie, high carbohydrate, high sugar products that were really inconsistent in their THC levels and very vague when it came to dosing,” Cross told leading cannabis publication Leafly in 2018.

“Personally, I’m a health nut but I also have asthma, so my cannabis needs were pretty specific. I set about trying to create a product that worked for me: potent, consistent, easy to consume, and — crucially — healthy.”

But until now, a sugar-free version of their award-winning and iconic sativa gummy that is up to the brand’s high standards proved elusive.

“We didn’t want to compromise on anything, which is why it took us so long to release this product,” he states.

“Over the years, we created and tested many iterations of the sugar-free gummy using a variety of ingredients, flavors and sweeteners. It wasn’t until we landed on this recipe that we felt it was ready to be released.”

“In terms of taste alone, this is my favorite KushyPunch product, hands down,” adds Cross. “Finding the right consistency is the hardest part,” adds KushyPunch’s chief scientist Carolina Vasquez Mitchell, a notable honoree of Dope Magazine’s Outstanding Women in Cannabis. “It’s not as simple as swapping out our regular syrup for a substitute like stevia. We tried about 20 different recipes and many different ingredients, and we all felt like this was really it.”

“With so many people turning to cannabis for relief and wellness, our new sugar-free gummy allows patients to ingest only the healthiest, natural ingredients and to dose with absolute confidence,” said Ruben.

KushyPunch’s sugar-free lychee gummy is available in dispensaries across California from April 2019.

If you would like to review this product, or interview Ruben Cross, reach out to ross@kushypunch.com.

Key Facts About KushyPunch’s Sugar-Free Gummy

  • The first cannabis-infused sugar-free gummy on the market
  • 100% natural lychee flavor
  • 100mg of THC from full-spectrum cannabis oil
  • No artificial colors or sweeteners
  • 2.5 kcal per serving
  • Low glycemic index and low insulin response
  • Non-cariogenic, making it healthier for your teeth
  • Tested by an ISO certified laboratory

About KushyPunch

KushyPunch is one of Southern California’s iconic and award-winning edible brands. Best known for its line of top-selling full spectrum gummies, KushyPunch has built its reputation on delivering a consistent, full body experience for patients and recreational consumers across California.

To learn more, visit https://kushypunch.com/

It’s sister brand KushyCBD brings the best practices of KushyPunch into the emerging CBD market. Created and tested in state-of-the-art facilities with the highest quality full spectrum oil, KushyCBD’s diverse product line includes their classic gummy, an all-in-one vape, omega-3 rich gel caps, and a sublingual mango tincture.

To learn more, visit https://kushycbd.com

End


Looking out the passenger window of a moving car.

Massachusetts Gives Preliminary Approval to Cannabis Delivery

The Massachusetts Cannabis Control Commission (CCC) has given preliminary approval to allow cannabis delivery services, the Associated Press reports. The plan was approved 4-1 but will need final approval after officials develop regulations.

For the first two years, delivery businesses would be limited to social equity applicants – those disproportionately impacted by previous cannabis laws. The draft rules would allow delivery businesses to pick up cannabis from retailers and deliver it to residences in municipalities where commercial sales are permitted.

“Delivery is an important thing to do. I believe we’re ready. This is going to make it more accessible for consumers… and it’s a very important thing from a social equity standpoint, because of the lower barriers to entry in terms of the capital requirements.” — Cannabis Commission Chairman Steve Hoffman, via the Boston Globe

During last week’s meetings, the CCC also discussed providing application fee waivers and reducing the first annual license fee for social equity and Economic Empowerment Program applicants, eliminating the $50 patient registration fee, developing potential potency limits, adding post-traumatic stress disorder to the list of qualifying conditions for medical cannabis, adding veterans to the Social Equity Program, and increasing patient caps for caregivers, according to a press release.

The agency also discussed stronger penalties for companies that violate licensing limits. Last month, regulators launched an investigation into Sea Hunter Therapeutics and Acreage Holdings alleging that they used shell companies to thwart the state’s six-total dispensary rules.

Next month, regulators are expected to deliberate issues related to social consumption, which could be included during the commission’s Fall regulatory process.

End


Washington Passes Bill Reversing Misdemeanor Cannabis Convictions

On Saturday, April 27, a bill in Washington state requiring courts to vacate misdemeanor cannabis convictions upon request passed the Senate for the second time and is now on its way to the desk of Gov. Jay Inslee (D). The action came shortly after the House passed an amended version and despite opposition from the Washington Association of Sheriffs and Police Chiefs.

The bill, SB 5605, follows the governor’s Marijuana Justice Initiative, which provides a process for pardoning misdemeanor cannabis convictions. Like the governor’s “initiative,” applicants for the vacancy must have been 21 at the time of their arrest.

By vacating a conviction, eligible Washingtonians will have all references to the conviction removed from their record, allowing them to answer “No” when asked the question “Have you ever been convicted of a crime?” on housing or job applications. The court may choose not to vacate if applicants have criminal charges pending, if fewer than three years have passed since the terms of the sentence were met, or if the applicant has been convicted of a new crime.

According to a report prepared by the Marijuana Arrest Research Project, there were 240,000 possession arrests in Washington between 1986 and 2010. The report also found communities of color were disproportionately affected by cannabis arrests. Proponents of the legislation say that, by passing this bill, Washington will join other states trying to reverse the damage done to communities of color by unjust cannabis laws.

The bill was pushed for heavily by The Cannabis Alliance, a cannabis industry trade organization of which Ganjapreneur is a supporting member. “We put our time, energy and resources behind this effort because our membership voted ‘Expunging records for cannabis convictions’ as their #2 priority for this legislative session,” said Cannabis Alliance Executive Director Lara Kaminsky. 

 

End


A freshly trimmed cannabis nug lying on its side on a wooden table.

Connecticut Lawmakers Want 20% Overall Cannabis Tax Rate

Connecticut lawmakers are seeking an overall tax rate of 20 percent on adult-use cannabis products, the Hartford Courant reports. Under the plan, the proceeds would be sent to cities and communities that have been most impacted by the War on Drugs.

Lawmakers in the state are debating various cannabis legalization-related bills after they moved out of their respective committees in late March and earlier this month. House Speaker Joe Aresimowicz, a Democrat, opposed the idea of earmarking the funds – not because of where they are going but because earmarks are “really hard to live up to in a changing economy and a changing budget process.”

Aresimowicz said if the legislature doesn’t come up with a compromise on legalization before June 5 they might call a special session to come to an agreement.

The tax rate plan would keep Connecticut’s cannabis taxes on par with neighboring Massachusetts and includes a local option that would allow municipalities to add their own 3 percent sales tax.

“Naturally, we don’t want to incentivize anybody to go over the border to Massachusetts if they are going to purchase cannabis. We tried to keep our rate consistent with the overall effective rate of where Massachusetts is.” — Rep. Jason Rojas, via NBC Connecticut

Earlier this month, the Legislature’s Judiciary Committee approved cannabis charge expungement bill, a measure to ensure employers have the right to ban cannabis from the workplace, and legislation to create a driving under the influence test for cannabis. The adult-use bill was approved by the General Law Committee in late March.

End


Iowa Bill Eliminating Medical Cannabis THC Caps Moves to Gov.

The Iowa Senate has approved a bill to eliminate the 3 percent THC cap on medical cannabis products, moving it on to Gov. Kim Reynolds for her signature, according to a KHQA report. In lieu of the potency cap, dispensaries would not be allowed to sell more than 25 grams of medical cannabis during a 90-day period.

While the measure does not expand the qualifying conditions list, the law does change “untreatable pain” as an approved condition to “severe and chronic pain.” According to the state Department of Public Health, 58 percent of the program’s patients qualify for untreatable pain. It also allows nurse practitioners and physicians assistants to certify medical cannabis patients for the program – as of Apr. 18, there are 2,538 registered patients and 666 physicians sighed up to certify.

The bill, which passed 40-7 on the last day of the session, removes restrictions blocking felons from the program. Notably, the bill still does not allow patients to purchase flower products but eliminating the THC cap will allow them to manufacture and sell high-potency products like tinctures.

“I give you my word: This is not a step in the direction of recreational use of marijuana. It’s a step to help people who have a lot of pain.” — Sen. Brad Zaun, R-Urbandale, during a Senate floor debate, via KHQA

Just last week, the legislature sent Reynolds, a Republican, a bill legalizing industrial hemp production in the state. Reynolds is expected to sign the hemp bill but has previously opposed expanding the medical cannabis program.

Last year, the governor’s spokesperson told the Des Moines Register that Reynolds “believes further study would be needed before expanding the program.” She also opposes broad recreational legalization. Her office has not indicated whether or not she plans on signing the expansion law.

End


Missouri Sets Number of MMJ Facility Licenses

The Missouri Department of Health and Senior Services will initially license 60 medical cannabis cultivation facilities, 86 infusion manufacturing facilities, and 192 dispensaries, KHQA reports.

Dr. Randall Williams, DHSS Director said the number of canna-businesses in the state are “consistent with what is outlined in the Constitution.”

Licenses will be awarded using blind scoring which Lyndall Fraker, director of DHSS Section for Medical Marijuana Regulation, said will ensure that businesses selected for licenses will be those most capable of providing quality service to patients while adhering to the regulations we are implementing.”

The agency has previously announced draft rules for the state’s medical cannabis law, it’s seed-to-sale tracking system, qualifying patients and caregivers, dispensaries, and DHSS is accepting comments on those rules until May 15. All rules for the program must be finalized by June 4.

Licenses for facility applications will be accepted between Aug. 3-17. The deadline to complete the blind scoring process is Dec. 31.

Missouri voters approved medical cannabis in 2016.

End


Utah to License 10 Medical Cannabis Growers

Utah will license 10 cultivators to grow medical cannabis crops for the state’s medical cannabis patients, according to a KUTV report. Under the state law passed last year outdoor cultivators can grow up to 4 acres, while indoor grows are limited to 100,000 square feet.

Both the cultivation limits and the number of licenses will lead to over or undersupply, depending on who you ask.

Melissa Ure, a senior policy analyst with the state Department of Agriculture and Food, told KUTV that there would be an oversupply if all 10 cultivators were growing their max limits. Ure said the state’s 100,000 patient estimate is more than double what the department is planning.

Justin Arriola, a board member with Together for Responsible Use and Cannabis Education, believes the state’s patient counts will reach 180,000, which means that Utah’s cultivators would not be able to meet the demand. He pointed to Connecticut and New Jersey – which have similar grower caps – and said “the lesson there is…the amount of market demand is underestimated.”

Utah dispensaries are slated to open next year – many advocates are worried, however, about the state law limit of just seven retailers for the entire state.

End


Hawaii Passes Industrial Hemp Bill; Gov. Expected to Sign

Hawaii lawmakers have passed a bill to make permanent the state’s industrial hemp program, the Hawaii Tribune-Herald reports. The measure was passed on the last day available for conference committees to approve bills.

State Rep. Richard Creagan, a Democrat who was on one of the conference committees that passed the bill, called it “a victory for all the small farmers” of Hawaii. Creagan indicated Gov. David Ige would sign the legislation. A similar bill failed to pass last month.

Under the current program, the Board of Agriculture sets limits on the number of industrial hemp licenses given out by the state. Creagan said the committee removed language from the bill wherein that rule would have remained in place until the full program was established – which is expected next year.

“We don’t want to just stop giving people licenses,” Creagan said in the report. “We don’t want to look like we’re trying to keep people out.”

Currently, there are just 17 industrial hemp cultivators in the state. The newly passed bill includes language to add three full-time employees to run and oversee the new industry.

End


Timeline Emerges for Completion of Washington’s Traceability System

A clearer timeline for the complete implementation of Washington state’s cannabis traceability system, Leaf Data Systems (LDS), is beginning to emerge after more than a year and a half of delays and setbacks.

Meeting for the first time since January, the Washington State Liquor and Cannabis Board (LCB) Traceability Advisory Committee rescheduled the latest update, version 1.37.5 from June 14 to July 1. The update had already been rescheduled from early November to June.

According to a Cannabis Observer report, MJ Freeway has submitted eight potential release candidates but none have passed the LCB’s ten-day regression testing process. The ninth candidate will be submitted on May 7. Leaf Data Systems 1.40 — the version that will fulfill the contract MJ Freeway signed on July 11, 2017 — is scheduled for release on September 20, 2019. At that time, MJ Freeway will manage Leaf Data Systems on a monthly subscription basis at a cost of $600,000 per year. Still more updates to fix data quality bugs are scheduled for late 2019 and beyond.

Additionally, members of the advisory committee have raised concerns about the data integrity within Leaf Data Systems over the past year. The LCB is attempting to remediate this issue with a “Data Quality Project” that will assess, analyze, and resolve problems and monitor data quality within LDS.

Project manager Claire Olson said, “We don’t really know how big the breadbox is yet,” and that the LCB is attempting to gain an assessment that is, “a little more finite than ‘everything is bad.'”

“Talking to the enforcement guys has been a real eye-opening experience for me. It is the reason I stay here late at night trying to get these things sorted out.” — Olson, via The Cannabis Observer

The process to implement a new seed to sale traceability system in Washington has been plagued with problems since 2017 when long-time vendor Bio Track THC’s contract was not renewed by the LCB.

MJ Freeway won the contract to build a new state system. After missing their first deadline of October 31, 2017, however, the company has reported delays ever since. After reports of a hack and continued issues, the LCB then brought on Gardner Consulting to help identify issues holding the project up in the spring of 2018. During this period, the LCB issued several emergency license suspensions, each related to diversion and traceability issues.

End


Canadian Police Report No Increase in Stoned Driving Post-Legalization

Canadian police have reported no significant changes in the number of cannabis-related impaired driving crimes post legalization, the Canadian Press reports. However, police say it is too early to release hard data on the issue.

In Ontario, police said the bulk of charges filed under the new law was for driving a vehicle with cannabis readily available; the law requires cannabis products to be out of reach of the driver usually in the trunk.

In Manitoba, that number is just 87 in six months. Royal Canadian Mounted Police Sgt. Paul Manaigre attributed those charges to people not trying to hide their cannabis products from police in their vehicles.

“We provide a reminder to treat it like alcohol and store in the trunk instead of on the front seat.” – Manaigre, in an email to the Canadian Press.

According to the casual survey of police departments throughout the nation, only in Alberta were there a significant uptick in stoned driving charges. From Oct. 17 to Apr. 10, 58 people were cited with drug-impaired driving charges, compared to 32 during the same six-month period in 2018.

Chief Const. Mike Serr of the Abbotsford, British Columbia Police Department, who co-chairs the Canadian Association of Chiefs of Police’s drug advisory committee, said that while officers do crack down on illicit cannabis producers when they come to law enforcement’s attention, they are prioritizing investigations into deadly drugs like fentanyl and methamphetamine.

End


Survey: 51% of Americans Consider Cannabis Smell a “Problem”

According to a PSB Research, Civilized, Burson Cohn & Wolfe, and BuzzFeed News survey, 51 percent of Americans believe the odor of cannabis in public is a “problem,” compared to 60 percent of Canadians.

The survey did find a supermajority of Americans – 84 percent – favored legalization for either medial or recreational purposes and 60 percent said they supported a taxed and regulated cannabis industry. Of the American respondents, 27 percent were active cannabis consumers.

In Canada, 57 percent of respondents said they “dislike” or “hate” the smell of cannabis in public, compared with 23 percent of Americans. Sixty percent of Canadians called the smell of cannabis in public “a real problem.”

Among Americans, 18 percent said they enjoyed the smell and another 18 percent said they didn’t like it – 41 percent said they didn’t notice or didn’t care.

One-third of current American consumers said that the smell of cannabis in public was a problem, but just 10 percent said it was a major one. Among American non-consumers, 27 percent called it a major problem while 29 percent said it was a minor problem; 28 percent said the smell was “not really a problem” when walking down the street, while 21 percent said it wasn’t “a problem at all.”

1,000 adults aged 21-or-older were interviewed for the survey in the U.S. – 471 consumed cannabis regularly. In Canada, 602 people were surveyed, including 371 consumers.

End